Subscriber Total Access
Learn more
Buy this photo
Buy this photo
Walgreen cited generic drug introductions as the main factor behind its revenue drop in November.
ASSOCIATED PRESS
About this Article
A key revenue measurement for Deerfield-based Walgreen Co. came in lower than Wall Street expected once again last month, as the introduction of generic drugs continued to squeeze revenue for the nation's largest drugstore chain. But the company's shares climbed more than 4 percent Wednesday.Galleries by Category